Uroxatral brand of alfuzosin was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 2003. A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2009.
The most up-to-date information about Alfuzosin and other drugs can be found at the following sites.
- Alfuzosin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Alfuzosin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Alfuzosin - Detailed information from DrugBank.